CAMP4 Therapeutics CorporationCAMPNASDAQ
LOADING
|||
Switch Symbol:
Revenue Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year revenue growth rate
Latest
-46.89%
↓ 1347% below average
Average (39q)
-3.24%
Historical baseline
Range
High:74.48%
Low:-100.00%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -46.89% |
| Q2 2025 | 74.48% |
| Q1 2025 | 31.60% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | 0.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | -100.00% |
| Q3 2023 | -99.51% |
| Q2 2023 | -9.70% |
| Q1 2023 | -0.49% |
| Q4 2022 | 8.32% |
| Q3 2022 | 12.52% |
| Q2 2022 | -5.34% |
| Q1 2022 | -0.58% |
| Q4 2021 | -12.95% |
| Q3 2021 | -0.83% |
| Q2 2021 | -2.77% |
| Q1 2021 | -6.89% |
| Q4 2020 | 5.36% |
| Q3 2020 | 4.14% |
| Q2 2020 | -8.01% |
| Q1 2020 | -9.72% |
| Q4 2019 | 3.60% |
| Q3 2019 | 4.68% |
| Q2 2019 | 5.56% |
| Q1 2019 | -4.65% |
| Q4 2018 | -7.85% |
| Q3 2018 | 1.21% |
| Q2 2018 | 0.52% |
| Q1 2018 | 0.78% |
| Q4 2017 | 4.35% |
| Q3 2017 | 1.91% |
| Q2 2017 | 2.27% |
| Q1 2017 | 3.33% |
| Q4 2016 | -7.88% |
| Q3 2016 | -0.73% |
| Q2 2016 | 28.73% |
| Q1 2016 | -5.18% |
| Q4 2015 | 6.97% |